Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai,Craig M. Crews +1 more
TLDR
Induced protein degradation has the potential to reduce systemic drug exposure, the ability to counteract increased target protein expression that often accompanies inhibition of protein function and the potential ability to target proteins that are not currently therapeutically tractable, such as transcription factors, scaffolding and regulatory proteins.Abstract:
Small-molecule drug discovery has traditionally focused on occupancy of a binding site that directly affects protein function, and this approach typically precludes targeting proteins that lack such amenable sites. Furthermore, high systemic drug exposures may be needed to maintain sufficient target inhibition in vivo, increasing the risk of undesirable off-target effects. Induced protein degradation is an alternative approach that is event-driven: upon drug binding, the target protein is tagged for elimination. Emerging technologies based on proteolysis-targeting chimaeras (PROTACs) that exploit cellular quality control machinery to selectively degrade target proteins are attracting considerable attention in the pharmaceutical industry owing to the advantages they could offer over traditional small-molecule strategies. These advantages include the potential to reduce systemic drug exposure, the ability to counteract increased target protein expression that often accompanies inhibition of protein function and the potential ability to target proteins that are not currently therapeutically tractable, such as transcription factors, scaffolding and regulatory proteins.read more
Citations
More filters
Journal ArticleDOI
Structural basis of PROTAC cooperative recognition for selective protein degradation.
M.S. Gadd,Andrea Testa,Xavier Lucas,Kwok-Ho Chan,Wenzhang Chen,Douglas J. Lamont,Michael Zengerle,Alessio Ciulli +7 more
TL;DR: The results elucidate how PROTAC-induced de novo contacts dictate preferential recruitment of a target protein into a stable and cooperative complex with an E3 ligase for selective degradation.
Journal ArticleDOI
Kinase inhibitors: the road ahead
TL;DR: An overview of the novel targets, biological processes and disease areas that kinase-targeting small molecules are being developed against, highlight the associated challenges and assess the strategies and technologies that are enabling efficient generation of highly optimized kinase inhibitors are provided.
Journal ArticleDOI
Drugging the 'undruggable' cancer targets
TL;DR: Four scientists working in the 'undruggable' cancer research field are asked for their opinions on the most crucial advances, as well as the challenges and what the future holds for this important area of research.
Journal ArticleDOI
Targeting transcription factors in cancer - from undruggable to reality.
TL;DR: This Review discusses the various approaches that are being explored to target transcription factors in cancer, with many of the inhibitors developed from such approaches now advancing to early clinical trials.
Journal ArticleDOI
Expanding the medicinal chemistry synthetic toolbox
TL;DR: Opportunities for the expansion of the medicinal chemists' synthetic toolbox are highlighted to enable enhanced impact of new methodologies in future drug discovery.
References
More filters
Journal ArticleDOI
The druggable genome
Andrew L. Hopkins,Colin R. Groom +1 more
TL;DR: An assessment of the number of molecular targets that represent an opportunity for therapeutic intervention is crucial to the development of post-genomic research strategies within the pharmaceutical industry.
Journal Article
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
C. Focan,Seth M. Steinberg,M. Blichert-Toft,JF Forbes,Rory Collins,Stewart J. Anderson,R. Margreiter,C. S. Harwood,K. W. Andersen,G. Beighton,R. V. Borovik,EA Clarke,T Yasutomi,Walter Jonat,E. Mari,O. Abe,Richard Peto,Richard Gray,J. B. Vermorken,Bernard Asselain,Mitchell A Harris,Ingrid Tengrup,PC Lara,J.L. Laplanche,Sue Jackson,RJ Sylvester,H. Ueo,Pierre Fumoleau,R. Sauer,William C. Wood,Willi Sauerbrei,Rebecca Gelman,J. C. Redmond,Angelo Raffaele Bianco,Rodrigo Arriagada,M Hauer,Marie Overgaard,M. P. Cunningham,John L. Hayward,M. Kissin,Owen,W. Jack,Cooper,J. L. Pater,M. Ogawa,Jon Godwin,N Scorpiglione,Mike K. Palmer,H Johansen,H. Hayat,Aman U. Buzdar,Hyman B. Muss,H. Sonoo,David Riley,G. Brufman,MJ Piccart-Gebhart,John Bryant,R. Nissen,H. Koyama,J. Uchino,D. Parker,J Mace,M. Durand,G. Cocconi,Y. Morishita,CF Oliveira,R. L. Comis,A. Goldhirsch,M. Spielmann,J. E. Varhaug,Carsten Rose,J-B Bonte,A. R. Coates,C. S. McArdle,J. J. Price,Janet T. Powell,L. M. Vecchio,Martin Schumacher,Matthew Clarke,A. Nicolucci,Larry Norton,G. Mathe,H.H. Tooth,R. Huerta,A. Erazo Velásquez,Norman Wolmark,N. H. Gordon,Joan Houghton,Michael J. Baum,S. Gundersen,R. H. Creech,Gianni Bonadonna,D. C. Smith,R. J. Salmon,D.F. Hacking,R. C. Coombes,Kathleen I. Pritchard,Y. Lehingue,James J. Dignam,L. Mauriac,J. Myles,Sam Wieand,Spencer L. James,Carla I. Falkson,Carl Blomqvist,M. Belfiglio,H. L. Davis,AU Rubagotti,V. Gouon-Evans,K. Sawa,F. Pannuti,Francesco Boccardo,R. Abe,I.S. Fentiman,K. Sakai,T. M. Holdaway,Gloria Broadwater,Pinuccia Valagussa,M. G. Le,J. B. Dubois,Tae C Smith,J. Collins,M. Izuo,Manfred Kaufmann,C. K. Axelsson,Nancy E. Davidson,R Simon,AO de Lima,J. Yamashita,H. J. Trampisch,Jack Cuzick,S. Takashima,E. Robinson,G. Fountzilas,Lippman amp,Donna L. Berry,Henning T. Mouridsen,R. Wittes,A Kodric-Brown,R. M. Clark,D Jackson,N Corcoran,Umberto Veronesi,D. M. Dent,K Morimoto,C Davies,Y. Takatsuka,B Carstensen,Bernard Fisher,Lars-Gunnar Larsson,Cjh van de Velde,E. F. Lau,E. Greaves,P. Meier,Roger W. Blamey,John F. Forbes,Hma Yosef,R. Swindell,G. Bastert,Moïse Namer,JN Ingle,J. L. Misset,R. G. Kay,J. Benraadt,Christopher Hill,S. Romain,J. L. Haybittle,Karen N. Price,N. Wigler,R. Catalano,Judith M Bliss,Jfr Robertson,Lori J. Pierce,Vera J. Suman,Monica Castiglione,R D Rubens,H. Host,J. Albano,K. Kikuchi,A.J. Schauer,B. H. Mason,A Lewit-Bentley,Thierry Delozier,H.-J. Senn,Vilcoq,B Dil Blasio,T. Hakes,Douglass C. Tormey,J. Skolyszewski,K Welvaart,T. Tominaga,C. M. Rudenstam,JA Dongen,J. Costantino,S Bartholomeus,G. C. Mead,Michel Marty,Richard D. Gelber,M. Yoshida,McLaughlin,Mitch Levine,Joseph Ragaz,K. Enomoto,D Fournier,SB Schryver,V. J. Harvey,Udi Chetty,Y. Nomura,J. Lindtner,P. Forrest,N Cole Robert,Jacques Bonneterre,J. P. Lobelle,A. Bengry-Howell,P. Romestaing,I. C. Henderson,P Martin-Sanz,T. Palshof,G. C. Ribeiro,E Hannisdal,A. H. Gervasio,K. Sugimachi,Charles L. Shapiro,R. E. Crossley,C. Cirrincione,I. M. Jackson,Michael Gnant +226 more
TL;DR: The age-specific benefits of polychemotherapy appeared to be largely irrespective of menopausal status at presentation, oestrogen receptor status of the primary tumour, and of whether adjuvant tamoxifen had been given.
Journal ArticleDOI
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander,J. Keith Joung +1 more
TL;DR: A modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells, which will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.
Journal ArticleDOI
The Ubiquitin Code
David Komander,Michael Rape +1 more
TL;DR: The structure, assembly, and function of the posttranslational modification with ubiquitin, a process referred to as ubiquitylation, controls almost every process in cells.
Journal ArticleDOI
Knocking down barriers: advances in siRNA delivery
TL;DR: An update on the progress of RNAi therapeutics is provided and novel synthetic materials for the encapsulation and intracellular delivery of nucleic acids are highlighted.
Related Papers (5)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson,Alina Mares,Ian Edward David Smith,Ko Eunhwa,Sebastien Andre Campos,Afjal Hussain Miah,Katie E Mulholland,Natasha Routly,Dennis L. Buckley,Jeffrey L. Gustafson,Nico Zinn,Paola Grandi,Satoko Shimamura,Giovanna Bergamini,Maria Faelth-Savitski,Marcus Bantscheff,Carly S. Cox,Deborah A. Gordon,Ryan R. Willard,John J. Flanagan,Linda N. Casillas,Bartholomew J. Votta,Willem den Besten,Kristoffer Famm,Laurens Kruidenier,Paul S. Carter,John D. Harling,Ian Churcher,Craig M. Crews +28 more